These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26301882)

  • 21. Simpson's paradox in the integrated discrimination improvement.
    Chipman J; Braun D
    Stat Med; 2017 Dec; 36(28):4468-4481. PubMed ID: 29160558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Several methods to assess improvement in risk prediction models: extension to survival analysis.
    Chambless LE; Cummiskey CP; Cui G
    Stat Med; 2011 Jan; 30(1):22-38. PubMed ID: 20827726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical risk reclassification at 10 years.
    Cook NR; Demler OV; Paynter NP
    Stat Med; 2017 Dec; 36(28):4498-4502. PubMed ID: 29156504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the incremental value of new biomarkers with integrated discrimination improvement.
    Kerr KF; McClelland RL; Brown ER; Lumley T
    Am J Epidemiol; 2011 Aug; 174(3):364-74. PubMed ID: 21673124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating a New Risk Marker's Predictive Contribution in Survival Models.
    Liu M; Kapadia AS; Etzel CJ
    J Stat Theory Pract; 2010 Dec; 4(4):845-855. PubMed ID: 22984361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved nonparametric estimation of the optimal diagnostic cut-off point associated with the Youden index under different sampling schemes.
    Yin J; Samawi H; Linder D
    Biom J; 2016 Jul; 58(4):915-34. PubMed ID: 26756282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additional value of B-type natriuretic peptide on discrimination of patients at risk for mortality after a non-ST-segment elevation acute coronary syndrome.
    García-Alvarez A; Regueiro A; Hernández J; Kasa G; Sitges M; Bosch X; Heras M
    Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):132-40. PubMed ID: 24448752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Net Reclassification Improvement.
    Jewell ES; Maile MD; Engoren M; Elliott M
    Anesth Analg; 2016 Mar; 122(3):818-824. PubMed ID: 26891393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semiparametric transformation models for multiple continuous biomarkers in ROC analysis.
    Kim E; Zeng D; Zhou XH
    Biom J; 2015 Sep; 57(5):808-33. PubMed ID: 26138227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nested logistic regression models and ΔAUC applications: Change-point analysis.
    Lee CY
    Stat Methods Med Res; 2021 Jul; 30(7):1654-1666. PubMed ID: 34125622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inference for the difference in the area under the ROC curve derived from nested binary regression models.
    Heller G; Seshan VE; Moskowitz CS; Gönen M
    Biostatistics; 2017 Apr; 18(2):260-274. PubMed ID: 27655817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What to expect from net reclassification improvement with three categories.
    Pencina KM; Pencina MJ; D'Agostino RB
    Stat Med; 2014 Dec; 33(28):4975-87. PubMed ID: 25176621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically relevant measures of fit? A note of caution.
    Cook NR
    Am J Epidemiol; 2012 Sep; 176(6):488-91. PubMed ID: 22875759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Useful tests of usefulness of new risk factors: tools for assessing reclassification and discrimination.
    Sundström J; Byberg L; Gedeborg R; Michaëlsson K; Berglund L
    Scand J Public Health; 2011 Jun; 39(4):439-41. PubMed ID: 21270137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Net reclassification index at event rate: properties and relationships.
    Pencina MJ; Steyerberg EW; D'Agostino RB
    Stat Med; 2017 Dec; 36(28):4455-4467. PubMed ID: 27426413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating incremental values from new predictors with net reclassification improvement in survival analysis.
    Zheng Y; Parast L; Cai T; Brown M
    Lifetime Data Anal; 2013 Jul; 19(3):350-70. PubMed ID: 23254468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.
    Pencina MJ; D'Agostino RB; Steyerberg EW
    Stat Med; 2011 Jan; 30(1):11-21. PubMed ID: 21204120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Net reclassification indices for evaluating risk prediction instruments: a critical review.
    Kerr KF; Wang Z; Janes H; McClelland RL; Psaty BM; Pepe MS
    Epidemiology; 2014 Jan; 25(1):114-21. PubMed ID: 24240655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.